Developer docs
API playgroundTry for free, no card

Search company profiles

TJP Labs

Full company profile

uuid000eel7

Namestring
TJP Labs
Legal namestring
TJP Labs Inc.
Websiteurl
tjplabs.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

TJP Labs Inc. is a private Canadian contract manufacturer specializing in modern oral buccal delivery pouches, headquartered in a 30,000 sq ft cGMP/HACCP-compliant, ISO 9001:2015-certified facility in Pickering, Ontario. The company operates a three-vertical product platform — Modern Oral Tobacco Alternatives (nicotine pouches), Modern Oral Energy Pouches (caffeine delivery), and Modern Oral Nutraceutical Pouches — built on world-class G.D S.p.A European manufacturing machinery with internal precision X-ray purity control, auto weighing and photography systems, and a cloud-based quality management platform. TJP has filed a patent application for a novel nicotine particulate technology claiming superior release characteristics relative to Polacrilex, and its subsidiary L!X Innovations markets the L!X nicotine pouch brand which received FDA PMTA acceptance in January 2022.

The company's go-to-market is enterprise B2B field sales targeting international tobacco and nicotine brands seeking turn-key private label, white-label, and co-packing solutions. Revenue is generated through contract manufacturing fees on production volume plus professional services revenue from R&D formulation, branding and packaging design, and global logistics. The most significant commercial validation to date is the 2024 divestiture of a 14-variant US nicotine pouches range to Imperial Brands (via ITG Brands) for £65 million initial consideration plus a five-year volume-based earnout, under which TJP retains the manufacturing contract.

TJP Labs is a wholly owned subsidiary of KIK ASS Products Inc., with capital provided by the founders and early management team of KIK Custom Products. The company holds a distinctive regulatory stack including Health Canada DEL (with API approval), FDA FEI, Medical Device Establishment License, and Natural Health Products Site License, positioning it to extend from nicotine pouch manufacturing into broader pharmaceutical contract manufacturing. Leadership is led by CEO David Richmond-Peck, whose mission-driven origin stems from a personal commitment to harm reduction, and CFO Michael Presley, appointed in July 2023 with CPG and private equity operational experience.

Short descriptiontext

TJP Labs is a Canadian B2B contract manufacturer of modern oral nicotine, energy, and nutraceutical pouches, operating a 30,000 sq ft cGMP/HACCP-compliant facility in Pickering, Ontario with G.D S.p.A machinery. The company serves international tobacco brands and consumer goods companies with turn-key private label, co-packing, branding, and global logistics services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPickering, Canada
HQ citystring
Pickering
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract manufacturing, nicotine pouches, private label manufacturing, oral pouch manufacturing, buccal delivery products
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
Product category
Contract Manufacturing - Oral Nicotine Pouches
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Manufacturing Services
TypeTransaction Fee
Description

Full-service contract manufacturing for modern oral nicotine pouches, energy pouches, and nutraceutical pouches. Revenue generated through manufacturing fees based on production volume and order size.

tjplabs.com
2Private Label & White-Label Services
TypeProfessional Services
Description

End-to-end private label and co-packing solutions allowing brands to bring products to market under their own branding with TJP manufacturing the products.

tjplabs.com
3Branding & Packaging Services
TypeProfessional Services
Description

Full-service creative and custom packaging capabilities from initial concept to final design, supporting product development and marketing efforts.

tjplabs.com
4Global Logistics Services
TypeProfessional Services
Description

Advanced warehousing technologies and logistics services to ensure product integrity and delivery, potentially offered as a value-added service.

tjplabs.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Infrastructure, Personnel, Supply Chain, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1L!X
Description

Nicotine pouches brand marketed by subsidiary L!X Innovations Inc.

tjplabs.com
Core offering1 text field

TJP Labs is a full-service contract manufacturer specializing in bulk modern oral buccal delivery pouch products for international brands. The company manufactures modern oral tobacco alternatives (nicotine pouches), modern oral energy pouches, and modern oral nutraceutical pouches through private label, white-label, and co-packing arrangements. Services span the full value chain including R&D formulation, agile and mass manufacturing, branding and packaging, and global logistics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Phase 1 capacity exceeds 36 million pouches per month; Phase 2 planned to double capacity
+2 more records
Product overview1 text field

TJP Labs is North America's leading full-service contract manufacturer specializing in premium quality next-generation oral delivery products. The company operates a platform of three core product categories—Modern Oral Tobacco Alternatives (nicotine pouches including L!X brand), Modern Oral Energy Pouches (caffeine delivery), and Modern Oral Nutraceutical Pouches—supported by integrated service modules covering Research & Development, Agile & Mass Manufacturing, Private Label & Co-Packing, Branding & Packaging, and Global Logistics. This turn-key manufacturing solution enables brands to bring next-generation buccal delivery products from concept through global distribution.

Product and service3 records
1L!X Nicotine Pouches
CategoryCore Product - Nicotine Pouches
Description

Modern oral nicotine pouches marketed by subsidiary L!X Innovations Inc. for adult (21+) nicotine users who wish to transition to non-combustible, oral-use products. The brand received FDA PMTA acceptance in January 2022.

2Modern Oral Tobacco Alternatives
CategoryCore Product - Nicotine Pouches
Description

Premium quality nicotine pouches serving as smoke-free alternatives to traditional combustible tobacco products, supporting global harm reduction initiatives. Contract manufactured for international brands.

3Modern Oral Energy Pouches
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Imperial Brands, through its US operation ITG Brands, acquired a range of nicotine pouches from TJP Labs to facilitate entry into the US modern oral market. The acquisition includes 14 product variants. TJP Labs continues to manufacture the oral nicotine pouches under contract for ITG Brands. Initial consideration was £65 million with additional deferred sum based on sales volumes over five years. Following consumer testing, ITG Brands plans to relaunch the range in 2024 under a new brand supported by their existing US sales force.

2International Partners (Manufacturing Supply Chain)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

TJP Labs has built bridges with international partners for consistent product sourcing, manufacturing capability, licensing, certifications, and global logistics services. These partners uphold TJP's values to lead with integrity and innovation.

tjplabs.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US tobacco holding company whose Helix Innovations subsidiary manufactures on! nicotine pouches, one of the leading US pouch brands. Directly competes in the modern oral segment that TJP serves through contract manufacturing.

2NJOY
TypeEmerging player
Description

Public US tobacco harm reduction company in vapor products. Competes in the broader smoke-free nicotine category that TJP addresses through oral nicotine pouches, representing an adjacent public-market comparable for the harm reduction thesis.

TypeDirect peer
Description

Major TJP customer (via ITG Brands, £65M product acquisition) and a competitor with its own ZoneX nicotine pouch portfolio. Represents both significant contract revenue and customer concentration risk for TJP Labs.

TypeBroad incumbent
Description

Global tobacco multinational that acquired Swedish Match and owns the leading ZYN nicotine pouch brand. PMI competes in the same modern oral category TJP serves as a contract manufacturer, and represents both a competitive threat and a potential B2B customer.

TypeOthers
Description

Parent company affiliate and original investor through KIK ASS Products Inc. KIK is a CPG contract manufacturer in household, pool, and automotive categories and provides governance, capital, and operational know-how to TJP Labs through shared founders and management.

TypeBroad incumbent
Description

Global tobacco multinational with Velo nicotine pouches distributed across multiple markets. Operates a comparable modern oral nicotine product line and could be a customer or competitor for TJP's contract manufacturing services.

TypeDirect peer
Description

Swedish nicotine pouch and snus manufacturer with a similar premium oral nicotine product positioning. Closest direct peer to TJP Labs in terms of product format and category leadership in modern oral nicotine.

TypeEmerging player
Description

US tobacco holding company with modern oral nicotine and other smoke-free products. Smaller scale than the major tobacco multinationals but operating in the same category that TJP serves as a contract manufacturer.

TypeRegional player
Description

Swedish tobacco manufacturer with contract manufacturing and nicotine pouch capabilities. Comparable B2B manufacturing model and Nordic regional focus parallel to TJP's North American contract manufacturing position.

TypeBroad incumbent
Description

Global tobacco company with oral nicotine and snus products across multiple international markets. Competes in the same modern oral category and could become a partner or competitor for TJP's B2B manufacturing platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TJP Labs

Contract Manufacturing - Oral Nicotine Pouchestjplabs.com

TJP Labs is a Canadian B2B contract manufacturer of modern oral nicotine, energy, and nutraceutical pouches, operating a 30,000 sq ft cGMP/HACCP-compliant facility in Pickering, Ontario with G.D S.p.A machinery. The company serves international tobacco brands and consumer goods companies with turn-key private label, co-packing, branding, and global logistics services.

What TJP Labs does

TJP Labs Inc. is a private Canadian contract manufacturer specializing in modern oral buccal delivery pouches, headquartered in a 30,000 sq ft cGMP/HACCP-compliant, ISO 9001:2015-certified facility in Pickering, Ontario. The company operates a three-vertical product platform — Modern Oral Tobacco Alternatives (nicotine pouches), Modern Oral Energy Pouches (caffeine delivery), and Modern Oral Nutraceutical Pouches — built on world-class G.D S.p.A European manufacturing machinery with internal precision X-ray purity control, auto weighing and photography systems, and a cloud-based quality management platform. TJP has filed a patent application for a novel nicotine particulate technology claiming superior release characteristics relative to Polacrilex, and its subsidiary L!X Innovations markets the L!X nicotine pouch brand which received FDA PMTA acceptance in January 2022.

The company's go-to-market is enterprise B2B field sales targeting international tobacco and nicotine brands seeking turn-key private label, white-label, and co-packing solutions. Revenue is generated through contract manufacturing fees on production volume plus professional services revenue from R&D formulation, branding and packaging design, and global logistics. The most significant commercial validation to date is the 2024 divestiture of a 14-variant US nicotine pouches range to Imperial Brands (via ITG Brands) for £65 million initial consideration plus a five-year volume-based earnout, under which TJP retains the manufacturing contract.

TJP Labs is a wholly owned subsidiary of KIK ASS Products Inc., with capital provided by the founders and early management team of KIK Custom Products. The company holds a distinctive regulatory stack including Health Canada DEL (with API approval), FDA FEI, Medical Device Establishment License, and Natural Health Products Site License, positioning it to extend from nicotine pouch manufacturing into broader pharmaceutical contract manufacturing. Leadership is led by CEO David Richmond-Peck, whose mission-driven origin stems from a personal commitment to harm reduction, and CFO Michael Presley, appointed in July 2023 with CPG and private equity operational experience.

TJP Labs firmographics

Firmographics
Name
TJP Labs
Legal name
TJP Labs Inc.
Website
https://tjplabs.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
TJP Labs is a Canadian B2B contract manufacturer of modern oral nicotine, energy, and nutraceutical pouches, operating a 30,000 sq ft cGMP/HACCP-compliant facility in Pickering, Ontario with G.D S.p.A machinery. The company serves international tobacco brands and consumer goods companies with turn-key private label, co-packing, branding, and global logistics services.
Ownership category
akta.pro rank

Where TJP Labs is headquartered

Location

Headquarters

HQ city
Pickering
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

TJP Labs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Infrastructure, Personnel, Supply Chain, Technology or R&D, Operations

Revenue model

  1. Contract Manufacturing Services: Full-service contract manufacturing for modern oral nicotine pouches, energy pouches, and nutraceutical pouches. Revenue generated through manufacturing fees based on production volume and order size.
  2. Private Label & White-Label Services: End-to-end private label and co-packing solutions allowing brands to bring products to market under their own branding with TJP manufacturing the products.
  3. Branding & Packaging Services: Full-service creative and custom packaging capabilities from initial concept to final design, supporting product development and marketing efforts.
  4. Global Logistics Services: Advanced warehousing technologies and logistics services to ensure product integrity and delivery, potentially offered as a value-added service.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

TJP Labs product offering

Product offering

Core offering

TJP Labs is a full-service contract manufacturer specializing in bulk modern oral buccal delivery pouch products for international brands. The company manufactures modern oral tobacco alternatives (nicotine pouches), modern oral energy pouches, and modern oral nutraceutical pouches through private label, white-label, and co-packing arrangements. Services span the full value chain including R&D formulation, agile and mass manufacturing, branding and packaging, and global logistics.

Product overview

TJP Labs is North America's leading full-service contract manufacturer specializing in premium quality next-generation oral delivery products. The company operates a platform of three core product categories—Modern Oral Tobacco Alternatives (nicotine pouches including L!X brand), Modern Oral Energy Pouches (caffeine delivery), and Modern Oral Nutraceutical Pouches—supported by integrated service modules covering Research & Development, Agile & Mass Manufacturing, Private Label & Co-Packing, Branding & Packaging, and Global Logistics. This turn-key manufacturing solution enables brands to bring next-generation buccal delivery products from concept through global distribution.

Differentiator

Problem solved

Functional benefit

Brands

  • L!X: Nicotine pouches brand marketed by subsidiary L!X Innovations Inc.

Products and services

  • L!X Nicotine Pouches Modern oral nicotine pouches marketed by subsidiary L!X Innovations Inc. for adult (21+) nicotine users who wish to transition to non-combustible, oral-use products. The brand received FDA PMTA acceptance in January 2022.
  • Modern Oral Tobacco Alternatives Premium quality nicotine pouches serving as smoke-free alternatives to traditional combustible tobacco products, supporting global harm reduction initiatives. Contract manufactured for international brands.
  • Modern Oral Energy Pouches

Quantifiable outcome

  • Phase 1 capacity exceeds 36 million pouches per month; Phase 2 planned to double capacity
  • +2 more outcomes

Companies that use TJP Labs

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

TJP Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

TJP Labs partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Imperial Brands / ITG BrandscoreOEM/ Whitelabel/ Licensing PartnerImperial Brands, through its US operation ITG Brands, acquired a range of nicotine pouches from TJP Labs to facilitate entry into the US modern oral market. The acquisition includes 14 product variants. TJP Labs continues to manufacture the oral nicotine pouches under contract for ITG Brands. Initial consideration was £65 million with additional deferred sum based on sales volumes over five years. Following consumer testing, ITG Brands plans to relaunch the range in 2024 under a new brand supported by their existing US sales force.
  • International Partners (Manufacturing Supply Chain)minorStrategic or Co-development PartnerTJP Labs has built bridges with international partners for consistent product sourcing, manufacturing capability, licensing, certifications, and global logistics services. These partners uphold TJP's values to lead with integrity and innovation.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

TJP Labs competitors and assessment

Company assessment

Broad incumbents

  • Altria: US tobacco holding company whose Helix Innovations subsidiary manufactures on! nicotine pouches, one of the leading US pouch brands. Directly competes in the modern oral segment that TJP serves through contract manufacturing.
  • Philip Morris International: Global tobacco multinational that acquired Swedish Match and owns the leading ZYN nicotine pouch brand. PMI competes in the same modern oral category TJP serves as a contract manufacturer, and represents both a competitive threat and a potential B2B customer.
  • British American Tobacco: Global tobacco multinational with Velo nicotine pouches distributed across multiple markets. Operates a comparable modern oral nicotine product line and could be a customer or competitor for TJP's contract manufacturing services.
  • Japan Tobacco International: Global tobacco company with oral nicotine and snus products across multiple international markets. Competes in the same modern oral category and could become a partner or competitor for TJP's B2B manufacturing platform.

Emerging players

  • NJOY: Public US tobacco harm reduction company in vapor products. Competes in the broader smoke-free nicotine category that TJP addresses through oral nicotine pouches, representing an adjacent public-market comparable for the harm reduction thesis.
  • Turning Point Brands: US tobacco holding company with modern oral nicotine and other smoke-free products. Smaller scale than the major tobacco multinationals but operating in the same category that TJP serves as a contract manufacturer.

Direct peers

  • Imperial Brands: Major TJP customer (via ITG Brands, £65M product acquisition) and a competitor with its own ZoneX nicotine pouch portfolio. Represents both significant contract revenue and customer concentration risk for TJP Labs.
  • Skruf Snus AB: Swedish nicotine pouch and snus manufacturer with a similar premium oral nicotine product positioning. Closest direct peer to TJP Labs in terms of product format and category leadership in modern oral nicotine.

Others

  • KIK Custom Products: Parent company affiliate and original investor through KIK ASS Products Inc. KIK is a CPG contract manufacturer in household, pool, and automotive categories and provides governance, capital, and operational know-how to TJP Labs through shared founders and management.

Regional players

  • GN Tobacco: Swedish tobacco manufacturer with contract manufacturing and nicotine pouch capabilities. Comparable B2B manufacturing model and Nordic regional focus parallel to TJP's North American contract manufacturing position.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

TJP Labs social profiles

Digital presence

TJP Labs compliance and trust

Trust signal

Compliance6 records

TJP Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TJP Labs leadership team

Management profile

Number of profiles

Profiles2 records

TJP Labs subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

TJP Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TJP Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TJP Labs

What does TJP Labs do?

TJP Labs is a full-service contract manufacturer specializing in bulk modern oral buccal delivery pouch products for international brands. The company manufactures modern oral tobacco alternatives (nicotine pouches), modern oral energy pouches, and modern oral nutraceutical pouches through private label, white-label, and co-packing arrangements. Services span the full value chain including R&D formulation, agile and mass manufacturing, branding and packaging, and global logistics.

Is TJP Labs a public or private company?

TJP Labs is a private company. It is classified as corporate owned and is currently operating.

When was TJP Labs founded?

TJP Labs was founded in 2021. It employs 51 to 100 people.

Where is TJP Labs based?

TJP Labs is headquartered in Pickering, Canada, in the North America region.

How does TJP Labs make money?

Four revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are private Label & White-Label Services, branding & Packaging Services and global Logistics Services.

Who are TJP Labs's main competitors?

Broad incumbents on record are Altria, Philip Morris International, British American Tobacco and Japan Tobacco International. Emerging players are NJOY and Turning Point Brands. Direct peers are Imperial Brands and Skruf Snus AB. KIK Custom Products is listed as an others. GN Tobacco is listed as a regional player.

Does TJP Labs have an API?

No public API is recorded for TJP Labs.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Tobacco ReporterTobacco ReporterTJP Labs filed for patent protection in April 2024 for a novel nicotine particulate that speeds nicotine release compared to polacrilex. The technology offers customizable particle sizes and can be used in NRT and recreational products. The company expects initial evaluation data by Q2 2025 and plans to sell or license the IP.Tobacco ReporterPatent Filed for Pouch TechnologyTJP Labs filed a patent for a nicotine particulate that releases nicotine significantly faster than polacrilex, a common resin in nicotine replacement therapy. The technology offers customizable particle sizes, precise binding, and efficient raw material use, with initial evaluation data expected in Q2 2024.PR NewswirePatent Application by TJP Labs Inc. Signals Breakthrough in Nicotine Pouch TechnologyTJP Labs Inc. announced the filing of a groundbreaking patent application for a novel nicotine particulate technology designed for oral nicotine pouches, claiming dramatic improvements in nicotine release speed compared to traditional Polacrilex. The technology offers advantages including versatile particulate size customization, precision-targeted binding, efficient raw material loading, and eco-friendly composition. The company expects initial evaluation data to be available by late Q2 2024 and views the patent as a critical breakthrough in nicotine replacement therapies.PR NewswirePatent Application by TJP Labs Inc. Signals Breakthrough in Nicotine Pouch TechnologyTJP Labs Inc. has filed a groundbreaking patent application for a novel nicotine particulate technology that dramatically increases nicotine release speed compared to traditional Polacrilex. The technology features customizable particulate sizes, eco-friendly composition including biodegradable resins, and nicotine loading several orders of magnitude higher than existing solutions. The company anticipates initial evaluation data by late Q2 2024 and positions this innovation as a critical breakthrough in Nicotine Replacement Therapies and harm reduction products.PR NewswireTJP Labs Inc. Receives FDA Acceptance For Premarket Tobacco Product Application (PMTA)TJP Labs Inc. announced that its Premarket Tobacco Product Application (PMTA) for L!X nicotine pouches has been accepted by the U.S. Food and Drug Administration. The acceptance moves the application to the next stage of the regulatory review process, representing a key milestone for the company's next-generation oral nicotine product line marketed under its subsidiary L!X Innovations Inc. The company highlighted its Health Canada Drug Establishment License and cGMP certifications as foundations for servicing high-volume international markets.Tobacco ReporterFDA Accepts L!X Pouches’ PMTAThe FDA accepted TJP Labs' premarket tobacco product application for L!X nicotine pouches. The company states the pouches are for adult users who cannot or choose not to discontinue nicotine use. TJP Labs is a contract manufacturer based in Ontario, Canada.PR NewswireTJP Labs Inc. Receives FDA Acceptance For Premarket Tobacco Product Application (PMTA)TJP Labs received FDA acceptance of its PMTA for L!X nicotine pouches, marketed by its subsidiary L!X Innovations. The application moves forward in the PMTA review process. CEO David Richmond-Peck said the acceptance reflects the company's dedication to providing alternatives for adult users.GlobeNewswireTJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical IngredientsTJP Labs received a notice of compliance for Active Pharmaceutical Ingredients after a Health Canada audit, meeting all GMP requirements. The achievement supports its drug manufacturing strategy and enables further licensable activities. CEO David Richmond-Peck said the certification accelerates innovation in modern oral and beyond nicotine categories.GlobeNewswireTJP Labs Inc. Is Granted Drug Establishment Licensing (DEL) by Health CanadaHealth Canada granted TJP Labs Inc. a Drug Establishment License after a thorough regulatory assessment and GMP compliance. The license aligns with TJP Labs' goal to offer drug manufacturing services and augments its expertise in nicotine and nutraceutical pouches. The company plans to use the license to service high-volume brands in international markets.